Detalles de la búsqueda
1.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
N Engl J Med
; 381(25): 2416-2428, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851799
2.
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Gynecol Oncol
; 165(1): 23-29, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177279
3.
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001.
Int J Gynecol Cancer
; 32(1): 93-100, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799418
4.
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV).
Int J Gynecol Cancer
; 30(4): 509-514, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32139438
5.
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer.
Int J Gynecol Cancer
; 29(7): 1141-1147, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420414
6.
Association of TNFRSF10D DNA-methylation with the survival of melanoma patients.
Int J Mol Sci
; 15(7): 11984-95, 2014 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25003639
7.
Patient involvement in research within the Gynecological Cancer InterGroup: A call to action for a systematic approach: Results from a survey.
Health Sci Rep
; 6(12): e1735, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38045625
8.
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial.
Clin Cancer Res
; 29(9): 1698-1707, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36595569
9.
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation.
Cancers (Basel)
; 15(13)2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444554
10.
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.
Clin Cancer Res
; 29(20): 4068-4075, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37581616
11.
The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.
Int J Gynecol Cancer
; 22(3): 372-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22246403
12.
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial.
Eur J Cancer
; 174: 221-231, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36067615
13.
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors.
Cancer Sci
; 101(4): 1059-66, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20156214
14.
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
J Clin Oncol
; 38(32): 3753-3762, 2020 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822286
15.
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium.
Front Oncol
; 9: 832, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31552170
16.
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
Eur J Cancer
; 70: 111-121, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914241
Resultados
1 -
16
de 16
1
Próxima >
>>